This finding indicates a significant enrichment of TP53 mutations in late-stage CRC and aligns with previously published studies, including findings by Iacopetta et al. (2006), thereby supporting the analytical accuracy and validity of AI-HOPE (Supplementary Fig. S5, available as supplementary data at Bioinformatics online). Here, TP53 is linked to colorectal carcinoma.